| Financial Year |
March 31 2023 |
| Monetary Funds |
478,747,184.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
9,818,150.18 |
| Advances to Suppliers |
1,884,747.39 |
| Other Receivables |
171,946,794.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
117,379,297.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
502,462.97 |
| Other Current Assets |
11,228,083.08 |
| Total Current Assets |
797,888,723.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
37,638,844.06 |
| Investment Properties |
-- |
| Fixed Assetes |
3,130,752,787.94 |
| Under-construction Projects |
349,343,857.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,921,688.44 |
| R&D expenses |
-- |
| Goodwill |
270,758,791.05 |
| Long-Term Deferred and Prepaid Expenses |
2,146,749.96 |
| Deferred Income Tax Assets |
4,690,859.60 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,091,589,208.22 |
| Total Assets |
4,889,477,931.34 |
| Short-Term Loans |
498,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
51,702,231.27 |
| Accounts Received In Advance |
2,849,716.75 |
| Employee Compensation Payable |
11,163,427.18 |
| Taxes Payable |
49,630,878.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,593,018.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
95,747,327.60 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
740,976,467.47 |
| Long-term Loans |
134,901,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,000,000.00 |
| Deferred Income Tax Liabilities |
33,210,279.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
356,077,323.74 |
| Total Liabilities |
1,097,053,791.21 |
| Paid-In Capital(Or Share Stock) |
469,144,503.00 |
| Capital Surplus |
960,097,950.27 |
| Surplus Reserve |
256,056,070.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,977,163,903.78 |
| Minority Stockholder's Interest |
126,060,188.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,666,363,951.17 |
| Owner's Equity（Stockholder's Equity） |
3,792,424,140.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,889,477,931.34 |
